TLDR
- Tilray Brands (TLRY) shares declined 3.36% to $3.59 following quarterly earnings release.
- First quarter revenue reached $257.1M, representing a 23% year-over-year increase.
- The company posted a $40 million net loss driven primarily by noncash charges.
- Beverage segment revenue soared 82% to $101.5M, bolstered by BrewDog integration.
- Cannabis sales dropped to $56.1M while segment margins improved to 39%.
Tilray Brands (TLRY) experienced a 3.36% decline to $3.59 during Thursday’s trading session despite delivering notable revenue expansion. The stock regained some ground in extended trading on October 8, climbing 0.61% to $3.6120. First-quarter financial results revealed a $40 million net loss paired with 23% revenue growth compared to the prior year period.
First Quarter Results Show Strong Top-Line Growth With Bottom-Line Losses
Tilray delivered record quarterly revenue of $257.1 million for the three-month period concluded August 31, 2026. This figure represented a substantial increase from the $209.5 million recorded in the comparable quarter of the previous fiscal year. Gross profit advanced 35% to $77.5 million, driven by performance improvements in multiple business divisions.
Gross margin showed expansion from 27% to 30%, indicating enhanced profitability across the company’s diverse operations. The organization recorded a $40 million net loss, with noncash charges accounting for a significant portion of this deficit. Loss per share came in at $0.32, while adjusted losses totaled $3 million.
On an adjusted basis, the company reported a loss of $0.02 per share for the quarter. Adjusted EBITDA decreased to $9.2 million from the prior year’s $10.2 million. Company leadership noted that roughly $1.7 million in worldwide fuel surcharges contributed to the year-over-year EBITDA decline.
Beverage Division Excels While Cannabis Segment Contracts
The beverage division produced $101.5 million in quarterly revenue, marking an 82% jump from the year-ago period. Tilray’s acquisition of BrewDog played a key role in this dramatic expansion and strengthened the company’s position in the beverage market. Gross profit from beverages nearly reached double the prior year amount at $42 million, with margins climbing from 38% to 41%.
Cannabis operations saw revenue contract to $56.1 million from the previous year’s $64.5 million. The cannabis segment’s gross profit similarly declined to $22 million compared to $23.3 million in the prior-year quarter. However, the division achieved margin improvement, with gross margin rising to 39% from the earlier 36%.
Distribution operations generated $84.3 million in revenue, a 14% increase attributed to the company’s pharmaceutical distribution activities. The wellness segment maintained revenue near $15.3 million, though gross profit fell to $4.4 million. These varied outcomes demonstrated the diverse performance trajectories across Tilray’s cannabis, beverage, distribution, and wellness divisions.
Company Upholds Long-Term Financial Targets and Reduces Leverage
Tilray concluded the quarter holding $221.4 million in cash, restricted cash, and marketable securities. Throughout the fiscal year, the organization decreased its outstanding debt by $42 million. These financial moves bolstered the company’s balance sheet position as management focused on integrating recent acquisitions into existing operations.
Looking ahead to fiscal 2027, Tilray reiterated its adjusted EBITDA guidance range of $68 million to $75 million. Company executives anticipate improved financial results during the latter half of the fiscal year. Leadership specifically highlighted expectations for the fourth quarter to deliver substantial contributions to full-year performance.
Tilray’s strategic focus remains on expanding its footprint across cannabis, beverage, wellness, and pharmaceutical distribution sectors. The company’s collaboration with Carlsberg will enable production and distribution of select beer brands throughout the United States. This partnership is scheduled to commence on January 1, 2027, further diversifying Tilray’s beverage portfolio beyond current offerings.



